October 27, 2016 8:49 AM ET


Company Overview of Epizyme, Inc.

Key Executives for Epizyme, Inc.

NameBoard RelationshipsTitleAge
Robert B. Bazemore Jr.45 RelationshipsChief Executive Officer, President and Director48
H. Robert Horvitz Ph.D., M.D.95 RelationshipsCo-Founder and Chairman of the Scientific Advisory Board--
Yi Zhang Ph.D.15 RelationshipsScientific Co-Founder and Member of The Scientific Advisory Board--
Andrew E. Singer No RelationshipsChief Financial Officer, Executive Vice President of Finance & Administration and Treasurer45
Matthew E. Ros No RelationshipsChief Operating Officer49
View More Key Executives

Epizyme, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Robert B. Bazemore Jr. 45 RelationshipsEpizyme, Inc.48
H. Robert Horvitz Ph.D., M.D. 95 RelationshipsEpizyme, Inc.--
Yi Zhang Ph.D. 15 RelationshipsEpizyme, Inc.--
Carl S. Goldfischer M.D. 85 RelationshipsBay City Capital LLC57
David M. Mott 188 RelationshipsMersana Therapeutics, Inc.51
View All Board Members

Epizyme, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee M.D.Carl S. Goldfischer85 Relationships3 Executives
Compensation Committee David M. Mott188 Relationships3 Executives
Nominating Committee M.D.Carl S. Goldfischer85 Relationships2 Executives
Corporate Governance Committee M.D.Carl S. Goldfischer85 Relationships2 Executives
Advisory Board Ph.D., M.D.H. Robert Horvitz95 Relationships9 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation
Not meaningful
Total Value of Options$293.5K
Compensation as of Fiscal Year 2015
Epizyme, Inc. CEO Compensation
Industry Average


ChemoCentryx Promotes Susan M. Kanaya to Position of Executive Vice President, Chief Financial and Administrative Officer and Secretary
October 25, 2016 8:02 PM ET
China Regenerative Medicine International Limited Appoints Chen Chunguo as President, Effective October 25, 2016
October 25, 2016 10:35 AM ET
Agendia Announces Appointments to Medical Advisory Board
October 25, 2016 10:20 AM ET
Global Blood Therapeutics, Inc. Announces Resignation of Dr. Eleanor Ramos as Chief Medical Officer
October 24, 2016 8:34 PM ET
GenVec, Inc. Announces Board Changes
October 24, 2016 8:33 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Epizyme, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.